Cardiovascular risk in newly diagnosed type 2 diabetes patients in India

被引:18
|
作者
Unnikrishnan, A. G. [1 ]
Sahay, R. K. [2 ]
Phadke, Uday [3 ]
Sharma, S. K. [4 ]
Shah, Parag [5 ]
Shukla, Rishi [6 ]
Viswanathan, Vijay [7 ]
Wangnoo, S. K. [8 ]
Singhal, Santosh [9 ]
John, Mathew [10 ]
Kumar, Ajay [11 ]
Dharmalingam, Mala [12 ]
Jain, Subodh [13 ]
Shaikh, Shehla [14 ]
Verberk, Willem J. [15 ]
机构
[1] Chellaram Diabet Inst, Pune, Maharashtra, India
[2] Osmania Gen Hosp, Osmania Med Coll, Dept Endocrinol, Hyderabad, India
[3] Sahyadri Hosp, Pune, Maharashtra, India
[4] Galaxy Special Ctr, Jaipur, Rajasthan, India
[5] Gujarat Endocrine Ctr, Ahmadabad, Gujarat, India
[6] Dr Rishi Shukla Ctr Diabet & Endocrine Dis, Kanpur, Uttar Pradesh, India
[7] MV Hosp Diabetes, Chennai, Tamil Nadu, India
[8] Indraprashth Apollo Hosp, New Delhi, India
[9] Sparsh Hlth Care & CHS Apple Hosp, Gwalior, Madhya Pradesh, India
[10] Providence Endocrine & Diabet Specialty Ctr, Trivandrum, Kerala, India
[11] Diabet Care & Res Ctr, Patna, Bihar, India
[12] Bangalore Endocrinol & Ctr, Bangalore, Karnataka, India
[13] Diabet Care Ctr, Prayagraj, Uttar Pradesh, India
[14] KGN Diabet & Endocrinol Ctr, Mumbai, Maharashtra, India
[15] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands
来源
PLOS ONE | 2022年 / 17卷 / 03期
关键词
INSULIN-RESISTANCE; VASCULAR-DISEASE; METAANALYSIS; NICOTINE; MELLITUS; CHOLESTEROL; MECHANISMS; SMOKING; GOALS;
D O I
10.1371/journal.pone.0263619
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Type 2 diabetes mellitus (T2DM) worldwide continues to increase, in particular in India. Early T2DM diagnosis followed by appropriate management will result in more cardiovascular event free life years. However, knowledge of the cardiovascular profile of newly diagnosed T2DM patients is still limited. The aim of this study was to understand the extent of cardiovascular disease (CVD) risk of newly diagnosed T2DM patients in India. Methods A cross sectional observational study was conducted to evaluate clinical laboratory and socio-demographic parameters of 5,080 newly diagnosed T2DM patients (48.3 12.8 years of age; 36.7% female). In addition, we determined their cardiovascular risk according to the guidelines of the Lipid Association of India (LAI) and the criteria of the QRISK3 score. Results Of the newly T2DM diagnosed patients in India 2,007(39.5%) were classified as "High risk" and 3,073 (60.5%) were classified as "Very high risk" based on LAI criteria. On average, patients had 1.7 +/- 0.9 major atherosclerotic cardiovascular disease (ASCVD) risk factors. Low HDL-C value was the most frequent major risk (2,823; 55.6%) followed by high age (2,502; 49.3%), hypertension (2,141; 42.1%), smoking/tobacco use (1,078; 21.2%) and chronic kidney disease stage 3b or higher (568; 11.2%). In addition, 4,192 (82.5%) patients appeared to have at least one cholesterol abnormality and, if the latest LAI recommendations are applied, 96.5% (4,902) presented with lipid values above recommended targets. Based on the QRISK3 calculation Indian diabetes patients had an average CVD risk of 15.3 +/- 12.3%, (12.2 +/- 10.1 vs. 17.1 +/- 13.5 [p<0.001] for females and males, respectively). Conclusions Newly diagnosed Indian T2DM patients are at high ASCVD risk. Our data therefore support the notion that further extension of nationwide ASCVD risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Prevalence of microvascular complications in newly diagnosed patients with Type 2 diabetes
    Ali, Alia
    Iqbal, Farrukh
    Taj, Azeem
    Iqbal, Zafar
    Amin, Muhammad Joher
    Iqbal, Qasim Zafar
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (04) : 899 - 902
  • [42] HIGH BLOOD PRESSURE IN THE NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS
    Nelaj, Ergita
    Gjata, Margarita
    Kecaj, Irida
    Gjermeni, Ilir
    Tase, Mihal
    JOURNAL OF HYPERTENSION, 2023, 41 : E172 - E172
  • [43] The feature of the gut microbiota in patients with newly diagnosed type 2 diabetes
    Lobanova, K. G.
    Demidova, T. Y.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 202 - 202
  • [44] Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
    Raz, Itamar
    DIABETES CARE, 2013, 36 : S139 - S144
  • [45] Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
    DeFronzo, Ralph A.
    Eldor, Roy
    Abdul-Ghani, Muhammad
    DIABETES CARE, 2013, 36 : S127 - S138
  • [46] Increased Peak Thrombin in Newly Diagnosed Patients with Type 2 Diabetes
    Ay, Leyla
    Brix, Johanna Maria
    Hoellerl, Florian
    Ay, Cihan
    Koder, Silvia
    Pabinger, Ingrid
    Schernthaner, Guntram
    DIABETES, 2010, 59 : A614 - A614
  • [47] Microalbuminuria in newly diagnosed patients with early type 2 diabetes mellitus
    Fineberg, N
    Perry, RC
    Cronin, J
    Crowder, K
    DIABETES, 1999, 48 : A147 - A147
  • [48] Treatment Patterns in Patients with Newly Diagnosed Type 2 Diabetes in 2015
    Wu, Jianmin
    Xie, Jin
    Siew, Hoong Wong-Jacobosn
    Haynes, Virginia S.
    Zhao, Zhenxiang
    DIABETES, 2018, 67
  • [49] Effect of oral hypoglycaemic agent adherence on cardiovascular disease and mortality in patients with newly diagnosed type 2 diabetes
    Choi, J.
    Nam, S.
    Lee, D. -H.
    Kim, J.
    Jeon, H.
    Oh, T.
    DIABETOLOGIA, 2019, 62 : S567 - S568
  • [50] Variants of GCKR Affect Both β-Cell and Kidney Function in Patients With Newly Diagnosed Type 2 Diabetes The Verona Newly Diagnosed Type 2 Diabetes Study 2
    Bonetti, Sara
    Trombetta, Maddalena
    Boselli, Maria Linda
    Turrini, Fabiola
    Malerba, Giovanni
    Trabetti, Elisabetta
    Pignatti, Pier Franco
    Bonora, Enzo
    Bonadonna, Riccardo C.
    DIABETES CARE, 2011, 34 (05) : 1205 - 1210